{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T06:59:05Z","timestamp":1777705145799,"version":"3.51.4"},"reference-count":44,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T00:00:00Z","timestamp":1585094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNS"],"abstract":"<jats:p>Every newborn bloodspot screening (NBS) result for cystic fibrosis (CF) consists of two parts: a screening part in the laboratory and a clinical part in a CF centre. When introducing an NBS programme, more attention is usually paid to the laboratory part, especially which algorithm is most suitable for the region or the country. However, the clinical part, how a positive screening result is processed, is often underestimated and can have great consequences for the affected child and their parents. A clear algorithm for the diagnostic part in CF centres is also important and influences the performance of a CF NBS programme. The processing of a positive screening result includes the initial information given to the parents, the invitation to the sweat test, what to do if a sweat test fails, information about the results of the sweat test, the inconclusive diagnosis and the carrier status, which is handled differently from country to country. The time until the definitive diagnosis and adequate information is given, is considered by the parents and the CF team as the most important factor. The communication of a positive NBS result is crucial. It is not a singular event but rather a process that includes ensuring the appropriate clinicians are aware of the result and that families are informed in the most efficient and effective manner to facilitate consistent and timely follow-up.<\/jats:p>","DOI":"10.3390\/ijns6020025","type":"journal-article","created":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T13:10:47Z","timestamp":1585141847000},"page":"25","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Processing Newborn Bloodspot Screening Results for CF"],"prefix":"10.3390","volume":"6","author":[{"given":"J\u00fcrg","family":"Barben","sequence":"first","affiliation":[{"name":"Division of Paediatric Pulmonology &amp; CF Centre, Children\u2019s Hospital of Eastern Switzerland, 9006 St. Gallen, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7334-8708","authenticated-orcid":false,"given":"Jane","family":"Chudleigh","sequence":"additional","affiliation":[{"name":"School of Health Sciences, City, University of London, London EC1V 0HB, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,3,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-2600(16)00053-9","article-title":"Newborn screening for cystic fibrosis","volume":"4","author":"Castellani","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jcf.2016.12.012","article-title":"The expansion and performance of national newborn screening programmes for cystic fibrosis in Europe","volume":"16","author":"Barben","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2009.01.004","article-title":"European best practice guidelines for cystic fibrosis neonatal screening","volume":"8","author":"Castellani","year":"2010","journal-title":"J. Cyst. Fibros."},{"key":"ref_4","unstructured":"Wilson, J.M.G., and Jungner, G. (1968). Principles and Practice of Screening for Disease, World Health Organization. Public Health papers, No.34."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: The 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jcf.2015.12.003","article-title":"Newborn screening for cystic fibrosis\u2014The parent perspective","volume":"15","author":"Rueegg","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jcf.2019.04.004","article-title":"International approaches for delivery of positive newborn bloodspot screening results for CF","volume":"18","author":"Chudleigh","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2008.05.005","article-title":"Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report","volume":"153","author":"Farrell","year":"2008","journal-title":"J. Pediatr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jpeds.2007.03.002","article-title":"Diagnostic sweat testing: The Cystic Fibrosis Foundation guidelines","volume":"151","author":"LeGrys","year":"2007","journal-title":"J. Pediatr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2016.09.064","article-title":"Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation","volume":"181","author":"Farrell","year":"2017","journal-title":"J. Pediatr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jcf.2016.04.003","article-title":"A false positive newborn screening result due to a complex allele carrying two frequent CF-causing variants","volume":"15","author":"Bergougnoux","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jcf.2019.04.010","article-title":"Inconclusive diagnosis after a positive newborn bloodspot screening result for cystic fibrosis; clarification of the harmonised international definition","volume":"18","author":"Southern","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"ref_13","unstructured":"CLSI (2009). Sweat Testing: Sample Collection and Quantitative Chloride Analysis Approved Guideline, Clinical and Laboratory Standards Institute. [3rd ed.]."},{"key":"ref_14","unstructured":"Royal College of Paediatrics and Child Health (2020, March 25). Guidelines for the Performance of the Sweat Test for the Investigation of Cystic Fibrosis in the UK (Version 2). An Evidence Based Guideline 2014. Available online: http:\/\/www.acb.org.uk\/docs\/default-source\/committees\/scientific\/guidelines\/acb\/sweat-guideline-v2-1.pdf."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ppul.20235","article-title":"Sweat-testing in preterm and full-term infants less than 6 weeks of age","volume":"40","author":"Eng","year":"2005","journal-title":"Pediatric Pulmonol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ppul.24227","article-title":"Swiss Cystic Fibrosis Screening Group Comparison of two sweat test systems for the diagnosis of cystic fibrosis in newborns","volume":"54","author":"Rueegg","year":"2019","journal-title":"Pediatric Pulmonol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jpeds.2010.07.053","article-title":"The need for quality improvement in sweat testing infants after newborn screening for cystic fibrosis","volume":"157","author":"LeGrys","year":"2010","journal-title":"J. Pediatr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ppul.21318","article-title":"Predictors of insufficient sweat production during confirmatory testing for cystic fibrosis","volume":"46","author":"Kleyn","year":"2011","journal-title":"Pediatric Pulmonol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/ppul.21608","article-title":"Comparison of quantitative sweat chloride methods after positive newborn screen for cystic fibrosis","volume":"47","author":"Laguna","year":"2012","journal-title":"Pediatric Pulmonol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.jpeds.2005.08.015","article-title":"Sweat testing infants detected by cystic fibrosis newborn screening","volume":"147","author":"Parad","year":"2008","journal-title":"J. Pediatr."},{"key":"ref_21","first-page":"933","article-title":"Reliability of sweat-testing by the Macroduct collection method combined with conductivity analysis in comparison with the classic Gibson and Cooke technique","volume":"89","author":"Mastella","year":"2000","journal-title":"Acta Paediatr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1136\/adc.88.12.1126","article-title":"Evidence based guidelines for the performance of the sweat test for the investigation of cystic fibrosis in the UK","volume":"88","author":"Baumer","year":"2003","journal-title":"Arch. Dis. Child."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/clinchem\/32.7.1375","article-title":"Use of a new sample-collection device (Macroduct) in anion analysis of human sweat","volume":"32","author":"Cole","year":"1986","journal-title":"Clin. Chem."},{"key":"ref_24","first-page":"115","article-title":"Australasian Guideline (2nd Edition): An Annex to the CLSI and UK Guidelines for the Performance of the Sweat Test for the Diagnosis of Cystic Fibrosis","volume":"38","author":"Coakley","year":"2017","journal-title":"Clin. Biochem. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0022-3476(94)70314-0","article-title":"Clinical evaluation of the macroduct sweat collection system and conductivity analyzer in the diagnosis of cystic fibrosis","volume":"124","author":"Hammond","year":"1994","journal-title":"J. Pediatr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/adc.82.5.420","article-title":"Indirect measurements of sweat electrolyte concentration in the laboratory diagnosis of cystic fibrosis","volume":"82","author":"Heeley","year":"2000","journal-title":"Arch. Dis. Child."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1569-1993(02)00146-7","article-title":"Sweat conductivity and chloride titration for cystic fibrosis diagnosis in 3834 subjects","volume":"2","author":"Lezana","year":"2003","journal-title":"J Cyst. Fibros."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1258\/0004563001899348","article-title":"Micro-flowcell conductometric sweat analysis for cystic fibrosis diagnosis","volume":"37","author":"Webster","year":"2000","journal-title":"Ann. Clin. Biochem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpeds.2004.08.085","article-title":"Conductivity determined by a new sweat analyzer compared with chloride concentrations for the diagnosis of cystic fibrosis","volume":"146","author":"Barben","year":"2005","journal-title":"J. Pediatr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00431-007-0485-0","article-title":"Nanoduct sweat testing for rapid diagnosis in newborns, infants and children with cystic fibrosis","volume":"167","author":"Desax","year":"2008","journal-title":"Eur. J. Pediatr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2478\/v10042-010-0044-9","article-title":"Bilateral sweat tests with two different methods as a part of cystic fibrosis newborn screening (CF NBS) protocol and additional quality control","volume":"48","author":"Sands","year":"2010","journal-title":"Folia Histochem. Cytobiol."},{"key":"ref_32","first-page":"34","article-title":"Nanoduct sweat conductivity measurements in 2664 patients: Relationship to age, arterial blood gas, serum electrolyte profiles and clinical diagnosis","volume":"5","author":"Sezer","year":"2013","journal-title":"J. Clin. Med. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00431-015-2501-0","article-title":"Clinical evaluation of the Nanoduct sweat test system in the diagnosis of cystic fibrosis after newborn screening","volume":"174","author":"Dompeling","year":"2015","journal-title":"Eur. J. Pediatr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jcf.2015.12.024","article-title":"Measurement of fecal elastase improves performance of newborn screening for cystic fibrosis","volume":"15","author":"Barben","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jcf.2015.01.001","article-title":"Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening","volume":"14","author":"Munck","year":"2015","journal-title":"J. Cyst. Fibros."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e1377","DOI":"10.1542\/peds.2014-2081","article-title":"Inconclusive diagnosis of cystic fibrosis after newborn screening","volume":"135","author":"Ooi","year":"2015","journal-title":"Pediatrics"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/MCP.0000000000000314","article-title":"Cystic Fibrosis Screen Positive, inconclusive Diagnosis (CFSPID)","volume":"22","author":"Barben","year":"2016","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ppul.22933","article-title":"Uncertain diagnosis after newborn screening for cystic fibrosis: An ethics-based approach to a clinical dilemma","volume":"49","author":"Massie","year":"2014","journal-title":"Pediatric Pulmonol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00004703-199206000-00005","article-title":"Parents\u2019 knowledge of neonatal screening and response to false-positive cystic fibrosis testing","volume":"13","author":"Tluczek","year":"1992","journal-title":"J. Dev. Behav. Pediatr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1542\/peds.2004-0275","article-title":"Psychosocial risk associated with newborn screening for cystic fibrosis: Parents\u2019 experience while awaiting the sweat-test appointment","volume":"115","author":"Tluczek","year":"2005","journal-title":"Pediatrics"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Chudleigh, J., Chinnery, H., Bonham, J.R., Olander, E.K., Moody, L., Simpson, A., Morris, S., Ulph, F., Bryon, M., and Southern, K.W. (2020). A Qualitative Exploration of Health Professionals\u2019 Experiences of Communicating Positive Newborn Bloodspot Screening Results for Nine Conditions in England, (In Press).","DOI":"10.1136\/bmjopen-2020-037081"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1080\/10810730.2010.522226","article-title":"Parental information seeking following a positive newborn screening for cystic fibrosis","volume":"15","author":"Dillard","year":"2010","journal-title":"J. Health Commun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10897-013-9675-2","article-title":"Informing children of their newborn screening carrier result for sickle cell or cystic fibrosis: Qualitative study of parents\u2019 intentions, views and support needs","volume":"23","author":"Ulph","year":"2014","journal-title":"J. Genet. Couns."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1073\/pnas.1914912117","article-title":"Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions","volume":"117","author":"Miller","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["International Journal of Neonatal Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2409-515X\/6\/2\/25\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:11:33Z","timestamp":1760173893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2409-515X\/6\/2\/25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,25]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["ijns6020025"],"URL":"https:\/\/doi.org\/10.3390\/ijns6020025","relation":{},"ISSN":["2409-515X"],"issn-type":[{"value":"2409-515X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,25]]}}}